[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370647-105":59,"doc-detail-370647-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","recent-advances-and-challenges-in-colorectal-cancer-from-molecular-research-to-treatment","Recent advances and challenges in colorectal cancer: From molecular research to treatment","","Colorectal cancer (CRC) ranks among the leading causes of cancer-related death globally. Advances in genomics, proteomics, and bioinformatics have clarified CRC’s molecular basis, enabling targeted therapies and immunotherapies. Persistent barriers include tumor heterogeneity, drug resistance, and the complex tumor microenvironment, alongside immunotherapy adverse effects. Artificial intelligence can leverage genetic and clinical data for risk, prognosis, and treatment-response prediction, while organoid systems model tumor behavior for drug testing and personalized therapy development. Ongoing needs include improving AI data quality and privacy practices, standardizing organoid culture, and refining therapeutic strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/recent-advances-and-challenges-in-colorectal-cancer-from-molecular-research-to-treatment/370647/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/recent-advances-and-challenges-in-colorectal-cancer-from-molecular-research-to-treatment/370647.png","ImageObject",300,407,{"name":92,"@type":93},"Melati","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the article focus on for colorectal cancer?","Question",{"text":112,"@type":113},"It reviews recent advances and ongoing challenges in colorectal cancer, moving from molecular research to treatment innovation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do artificial intelligence and organoids contribute to CRC research and treatment?",{"text":117,"@type":113},"AI analyzes genetic and clinical data to predict risk, prognosis, and treatment response, while organoids replicate tumor traits for drug testing and personalized therapeutic planning.",{"name":119,"@type":110,"acceptedAnswer":120},"What major obstacles are highlighted for improving CRC treatment outcomes?",{"text":121,"@type":113},"The article emphasizes tumor heterogeneity, drug resistance, limitations and adverse effects of immunotherapies, and challenges in AI data quality/privacy and organoid culture standardization.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370647,1790272999,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085570644,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","| W | J | G | World Journal of\u003Cbr>Gastroenterology |\n| --- | --- | --- | --- |\n\nSubmit a Manuscript: [https://www.f6publishing.com](https://www.f6publishing.com)  \n[DOI:](DOI: 10.3748/wjg.v31.i21.106964)[ 10.3748/wjg.v31.i21.106964](DOI: 10.3748/wjg.v31.i21.106964)  \nWorld J Gastroenterol 2025 June 7; 31(21): 106964 ISSN 1007-9327 (print) ISSN 2219-2840 (online)  \nREVIEW  \nRecent advances and challenges in colorectal cancer: From molecular research to treatment  \nGao-Xiu Qi, Rui-Xia Zhao, Chen Gao, Zeng-Yan Ma, Shang Wang, Jing Xu  \nSpecialty type: Gastroenterology and hepatology  \nProvenance and peer review:  \nUnsolicited article; Externally peer reviewed.  \nPeer-review model: Single blind  \nPeer-review report’s classification Scientific Quality: Grade A, Grade C, Grade C  \nNovelty: Grade A, Grade C, Grade C  \nCreativity or Innovation: Grade A, Grade C, Grade C  \nScientific Significance: Grade B, Grade B, Grade C  \nP-Reviewer: Li HB; Li XY; Yang N  \nReceived: March 12, 2025  \nRevised: April 22, 2025  \nAccepted: May 26, 2025  \nPublished online: June 7, 2025  \nProcessing time: 86 Days and 13.4 Hours  \nGao-Xiu Qi, Rui-Xia Zhao, Chen Gao, Zeng-Yan Ma, Jing Xu, Department of Pathology, Qingdao Central Hospital, University of Health and Rehabilitation Sciences (Qingdao Central Medical Group), Qingdao 266042, Shandong Province, China  \nShang Wang, Department of Pathology, School of Basic Medicine, Qingdao University, Qingdao 266071, Shandong Province, China  \nCorresponding author: Jing Xu, MD, Chief Physician, Department of Pathology, Qingdao Central Hospital, University of Health and Rehabilitation Sciences (Qingdao Central Medical Group), No. 127 Siliu South Road, Shibei District, Qingdao 266042, Shandong Province, [China.](China. katherine_xu@163.com)[ katherine_xu@163.com](China. katherine_xu@163.com)  \nAbstract  \nColorectal cancer (CRC) ranks among the top causes of cancer-related fatalities globally. Recent progress in genomics, proteomics, and bioinformatics has greatly improved our comprehension of the molecular underpinnings of CRC, paving the way for targeted therapies and immunotherapies. Nonetheless, obstacles such as tumor heterogeneity and drug resistance persist, hindering advancements in treatment efficacy. In this context, the integration of artificial intelligence (AI) and organoid technology presents promising new avenues. AI can analyze genetic and clinical data to forecast disease risk, prognosis, and treatment responses, thereby expediting drug development and tailoring treatment plans. Organoids replicate the genetic traits and biological behaviors of tumors, acting as platforms for drug testing and the formulation of personalized treatment approaches. Despite notable strides in CRC research and treatment-from genetic insights to therapeutic innovations-numerous challenges endure, including the intricate tumor microen-vironment, tumor heterogeneity, adverse effects of immunotherapies, issues related to AI data quality and privacy, and the need for standardization in organoid culture. Future initiatives should concentrate on clarifying the pathogenesis of CRC, refining AI algorithms and organoid models, and creating more effective therapeutic strategies to alleviate the global impact of CRC.  \nKey Words: Colorectal cancer; Molecular; Treatment; Artificial intelligence; Organoid  \n©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.  \n WJG  [https://www.wjgnet.com](https://www.wjgnet.com) 1 June 7, 2025  Volume 31  Issue 21   \nQi GX et al. CRC molecular and treatment research and challenges  \nCore Tip: This study highlights recent advances and challenges in colorectal cancer from molecular research to treatment. Advances in genomics, proteomics, and bioinformatics have significantly enhanced our understanding of colorectal cancer’s molecular mechanisms, driving targeted therapies and immunotherapies. However, tumor heterogeneity and drug resistance remain major hurdles. Artific","cbCaiuRkEcsAvd84","https://ap.wps.com/l/cbCaiuRkEcsAvd84","pdf",6051116,31,"English","# Abstract\n# Key words\n# Core Tip\n# Citation\n# Content Overview","[{\"question\":\"What does the article focus on for colorectal cancer?\",\"answer\":\"It reviews recent advances and ongoing challenges in colorectal cancer, moving from molecular research to treatment innovation.\"},{\"question\":\"How do artificial intelligence and organoids contribute to CRC research and treatment?\",\"answer\":\"AI analyzes genetic and clinical data to predict risk, prognosis, and treatment response, while organoids replicate tumor traits for drug testing and personalized therapeutic planning.\"},{\"question\":\"What major obstacles are highlighted for improving CRC treatment outcomes?\",\"answer\":\"The article emphasizes tumor heterogeneity, drug resistance, limitations and adverse effects of immunotherapies, and challenges in AI data quality/privacy and organoid culture standardization.\"}]","Recent advances and challenges in colorectal cancer: From molecular research to treatment | PDF",1790189632,78,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/34d77f9e424167d4c689702e716db5c9.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8085e392fd903f57b05728fd5927cfc.webp",982,1389,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8730fa2191ea528651216c6ce3796a4d.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b2dcb83de47a2075f9d46cb1aed137f.webp",980,1386]